BERLIN – Spain will stop administering the AstraZeneca coronavirus vaccine for two weeks, while experts review its safety, Health Minister Carolina Dias announced Monday.
Other European Union countries, including France, Germany and Italy, have also temporarily stopped using the AstraZeneca jab amid reports that some people developed blood clots after receiving the injection.
Dias announced the “preventive and temporary” measure at a press conference in Madrid, after consulting the regional governments of Spain.
Some of Spain’s 17 regions had already stopped applying the AstraZeneca jab, despite previous national government insistence that there was no evidence to justify the change in vaccine policy.
AstraZeneca and global health officials insist that the injection is safe.
Spain is only applying the jab to people under the age of 55, saying its effectiveness in older people has not been proven.
THIS IS AN UPDATE OF LATEST NEWS. The previous history of the AP follows below.
BERLIN (AP) – Germany, France and Italy on Monday were the last countries to suspend the use of AstraZeneca’s COVID-19 vaccine due to reports of dangerous blood clots in some recipients, although the company and European regulators have said that there is no evidence that the injection is to blame.
AstraZeneca’s formula is just one of three vaccines in use on the continent. But the move represents another setback for the launch of the European Union vaccine, which has been affected by shortages of supplies and other obstacles and is far behind campaigns in Britain and the United States.
The safety committee of the EU drug regulatory agency called a meeting on Thursday to review the experts’ conclusions about the AstraZeneca vaccine and decide whether action should be taken.
The furor comes as much of Europe is increasing restrictions on schools and businesses amid increasing cases of COVID-19.
Germany’s health minister said the decision to suspend AstraZeneca vaccines was taken on the advice of the country’s vaccine regulator, the Paul Ehrlich Institute, which called for a more in-depth investigation into seven reported cases of clots in the brains of people who were vaccinated.
“Today’s decision is a purely precautionary measure,” said Jens Spahn.
French President Emmanuel Macron said his country would also stop shooting until at least Tuesday afternoon. He said France hopes to resume using the formula soon.
Italy’s drug regulator also announced a temporary and preventive ban, less than 24 hours after saying that the “alarm” about the vaccine “was not justified”.
AstraZeneca said there were 37 reports of blood clots in more than 17 million people vaccinated in the 27 countries of the European Union and Britain. The drugmaker said there is no evidence that the vaccine increases the risk of clots.
In fact, he said that the incidence of clots is much less than would be expected to occur naturally in a general population of this size and is similar to that of other licensed COVID-19 vaccines.
The World Health Organization and the European Medicines Agency of the EU also said that the data does not suggest that the vaccine caused the clots and that people should continue to be immunized.
“Many thousands of people develop blood clots in the EU each year for different reasons,” said the European Medicines Agency. The incidence in vaccinated persons “does not appear to be greater than that observed in the general population”.
The agency said that, while the investigation is ongoing, “the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects.”
Blood clots can travel through the body and cause heart attacks, strokes and deadly blockages in the lungs. AstraZeneca has reported 15 cases of deep vein thrombosis, or a type of clot that often develops in the legs, and 22 cases of pulmonary embolisms or clots in the lungs.
AstraZeneca injection has become a key tool in European countries’ efforts to boost their slow vaccine implementations. It is also the pillar of a UN-supported project known as COVAX, which aims to bring COVID-19 vaccines to the poorest countries.
Vaccines from Pfizer and Moderna are also used on the European continent, and the Johnson & Johnson one-shot vaccine has been authorized, but has not yet been distributed.
In the United States, which depends on the Pfizer, Moderna and J&J vaccines, AstraZeneca must apply for authorization any day.
Denmark last week became the first country to temporarily suspend the use of the AstraZeneca vaccine in recent days. He said that a person developed clots and died 10 days after receiving at least one dose. The other countries include Ireland, Thailand, the Netherlands, Norway, Iceland, Congo and Bulgaria.
Last week, Germany and France were among the nations that followed the vaccine, while Italy suspended only a specific batch of the vaccine. Britain and Canada are defending the AstraZeneca vaccine for the time being.
Dr. Michael Head, a senior researcher in global health at the University of Southampton, England, said there is still no data to justify the suspension of the AstraZeneca vaccine and called the decision “disconcerting”.
“Stopping the launch of a vaccine during a pandemic has consequences,” said Head. “This results in delays in protecting people and the potential for increased hesitation to the vaccine, as a result of people who saw the headlines and, understandably, were concerned.”
Spahn, the German health minister, said of the decision to suspend the injection of AstraZeneca: “The most important thing for trust is transparency”. He said that both the first and second doses will be affected by the suspension.
German authorities have encouraged anyone who feels increasingly sick more than four days after receiving the injection – for example, with persistent headaches or bruises in the form of stitches – to seek medical attention.
Germany received just over 3 million doses of the AstraZeneca vaccine, and about half of them have already been administered, compared with almost 7 million doses of the Pfizer vaccine and about 285,000 from Moderna.
Europe, for its part, is re-imposing restrictions in an attempt to stem the resurgence of infections, many of which are variants of the original virus.
In Italy, 80% of children across the country were unable to attend classes after stricter rules in more regions came into effect on Monday. In Poland, tightened restrictions were applied to two more regions, including Warsaw. Paris can be confined in a matter of days because intensive care units are filling up with patients with COVID-19.
———
Sylvie Corbet in Paris, Maria Cheng in London and Frances D’Emilio in Rome contributed to this report.
———
Follow AP’s pandemic coverage at:
https://apnews.com/hub/coronavirus-pandemic
https://apnews.com/hub/coronavirus-vaccine
https://apnews.com/UnderstandingtheOutbreak